Navigation Links
Emerson Resources Announces CEO Retirement and Appointment of Successor

Norristown, PA (PRWEB) May 21, 2013

Emerson Resources Inc., a premier pharmaceutical development company, today announced that Dr. Charles Signorino, the Company’s Chief Executive Officer and Chairman of the Board, retired on April 1, 2013 after 32 years of service. As part of Emerson Resources’ planned leadership succession process, Adolfo Gomez, Emerson’s current President, has been named as Dr. Signorino’s successor.

Dr. Signorino is a recognized luminary in the pharmaceutical industry, having made a significant contribution to the field during his extensive career. He is an established expert in many aspects of tablet coating and holds 17 U.S. patents related to the area. Additionally, he is named in Who’s Who of American Scientists, has been published in numerous technical journals over the past three decades, and is a member of key industry organizations.

He joined Emerson Resources in 1981 as President and Chairman of the Board, following 20 years of service at Colorcon Inc. as Vice President and member of the Board of Directors. Dr. Signorino was elected CEO of Emerson Resources in 2002, based on his visionary leadership and notable expertise in Emerson’s core areas of focus. During his tenure at Emerson Resources, Dr. Signorino also formed CS Associates, a contract lab for coating services, in 1987.

“The entire team at Emerson Resources would like to express our gratitude to Dr. Signorino for his lifelong dedication to the field, as well as his steadfast service to the Company,” said Adolfo Gomez, President. “Dr. Signorino has set the bar very high for me as his successor. He has not only established the Company as a global name in the pharmaceutical and nutritional supplement industries, he has also inspired the Company with his strategic vision, passion for lifelong learning and strong family values.

Adolfo Gomez, a Principal of the Company with more than 20 years of industry experience, joined Emerson Resources in 2001. In his role as President, he has been responsible for managing every aspect of the business, with a specific focus on Business Development and Strategy. Mr. Gomez is credited for his instrumental role in diversifying Emerson Resources’ business model to include partnerships with industry leading organizations, as well as working very closely with Emerson’s management team to ensure adherence to the company’s core values.

In his new role as CEO, Mr. Gomez will continue implement a strategic plan that centers on three key areas of focus for the Company. These areas include:

  •     Ensuring the Company remains focused on helping clients with their drug development strategies that will allow them to bring their molecules to market as quickly and efficiently as possible.
  •     Maintaining the dynamic culture of creativity and ownership that differentiates Emerson Resources from the competition.
  •     Staying on the forefront of cutting edge technologies that allow the Company to maintain its reputation as an excellent problem solver, with pragmatic yet creative solutions.

“I am delighted to pass the opportunity to build on Emerson Resources’ history of innovation, service and success to Mr. Gomez," said Dr. Signorino. "He is a talented leader and I look forward to supporting him as he moves the Company to its next level of growth.”

About Emerson Resources
Emerson Resources’ reputation as a dependable, dynamic, flexible, and pragmatic
organization has been built on the core concepts of excellent service, superb quality and
complete client satisfaction. The Emerson mission is to deliver value-added service,
ingredients and expertise to the pharmaceutical and biotech industries.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wiley Job Network Announces New Resources and Tools to Connect Job Seekers and Employers
2. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
3. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
4. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
5. Cepheid Welcomes Senior Vice President of Human Resources
6. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
7. Revolutionary Science Announces New Automatic and Manual Colony Counting Products
8. Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing
9. SoundConnect Announces Microsoft Lync Release in Canada
10. GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit
11. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes
Post Your Comments:
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ - ... the request of IIROC on behalf of the Toronto ... this news release there are no corporate developments that ... price. --> --> ... --> . --> Aeterna Zentaris ...
Breaking Biology Technology:
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):